|
⚲
|
| Keyboard |
| Pepose Jay
✚
|
|
|---|---|
| CIK # | 0001866191 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001866191] | |
| 4 | [0001866191] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rexahn Pharmaceuticals Inc | |
| Pepose Jay |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-06-11 | Grant | 41,143 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 35,181 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-04-11 | Grant | 32,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (right to buy) · derivative
|
2024-04-11 | Grant | 48,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-01-01 | Grant | 14,964 | ||
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2023-11-01 | Grant | 35,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option · derivative
|
2023-06-06 | Grant | 9,639 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2023-06-06 | Grant | 10,976 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2023-04-19 | Grant | 468 | ||
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2023-01-11 | Grant | 13,013 | ||
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (right to buy) · derivative
|
2023-01-10 | Grant | 33,291 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2022-07-01 | Grant | 9,900 | ||
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (right to buy) · derivative
|
2022-06-13 | Grant | 20,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (right to buy) · derivative
|
2022-04-08 | Grant | 50,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2021-12-13 | Buy | 8,250 | $3.65 | 30,112 |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2021-09-13 | Buy | 12,631 | $4.75 | 59,997 |
|
Rexahn Pharmaceuticals Inc OCUP
Stock Option (right to buy) · derivative
|
2021-06-07 | Grant | 40,000 | $0.00 |